Edwards to add 370 employees in Costa Rica
Edwards Lifesciences (NYSE:EW) is slated to add 370 to its workforce in Costa Rica as part of an expansion plan in the region, according to a post from the Costa Rican Investment Promotion Agency (CINDE).
The Irvine, Calif.-based company originally established its facilities in Costa Rica in 2016, and currently employs 480 employees in the region.
“Edwards Lifesciences continues expanding with Costa Rica, generating new jobs in Cartago and adding value to the medical devices exports. In our country, the company has a high-tech plant for manufacturing cardiovascular valves which are exported worldwide. It is thanks ...
Source: Mass Device - December 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Edwards Lifesciences Source Type: news
New UMBC research suggests global reforestation efforts need to take the long view
(University of Maryland Baltimore County) Based on data from Costa Rica spanning 1947 -- 2014, the authors of a new study found 50 percent of secondary forest patches were re-cleared within 20 years, and 85 percent were re-cleared within 54 years. This suggests that committing to reforesting lands for the long term, even if smaller in total area, may provide greater benefits (habitat, carbon storage, etc.) than quickly reforesting large areas (as many nations have promised under the Bonn Challenge). (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 8, 2018 Category: Biology Source Type: news
Establishment Labs inks asset repurchasing deal with German, Spanish distributors
Breast implant maker Establishment Labs said today it inked a number of asset purchase agreements with distributors in Spain and Germany to repurchase stock they had previously held, according to an SEC filing.
The Costa Rica-based company said it inked an asset purchase deal with Motiva Matrix Spain SL for assets including all existing inventory previously sold to the seller, as well as its customer relationships and contracts for approximately $1.9 million (EU €1.6 million).
Establishment Labs said it also owes the distributor $2.3 million (EU €2.0 million) in outstanding debt, to be paid before the stock is repurc...
Source: Mass Device - October 4, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Establishment Labs Source Type: news
Lifestyle migrants bring good intentions -- but major change -- to Costa Rica
(University of Kansas) A group of Americans and Europeans has relocated to a Costa Rican community in recent decades, and despite the government cheering the economic jolt, their isolation from locals there more highlights the privilege of these migrants who drastically transform coastal villages. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 12, 2018 Category: International Medicine & Public Health Source Type: news
Hologic ’ s Cynosure to close NY-based plant, layoff 30
Hologic (NSDQ:HOLX) subsidiary Cynosure is looking to lay off 30 workers at its Hicksville, N.Y.-based facilities, according to a newly released Worker Adjustment and Retraining Notification act posting.
The layoffs come as a result of the company closing its plant, which produced “irradiation apparatus” devices, according to the notice.
Hologic will move the production jobs to Massachusetts and Costa Rica, according to a report from Newsday. Departing employees were offered severance pay and outplacement benefits, according to the report.
The layoffs are slated to begin on December 14, and will proceed throu...
Source: Mass Device - August 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cynosure Inc. Hologic Source Type: news
Sensus Healthcare wins FDA nod for next-gen SRT-100+ radiation therapy system
Superficial radiation therapy device developer Sensus Healthcare (NSDQ:SRTSU) said today it won FDA 510(k) clearance for its SRT-100+ next-gen superficial radiation therapy system.
The newly cleared device includes all the features of the Boca Raton, Fla.-based company’s SRT-100 as well as an expanded energy range, remote diagnostics and operation tracking, a new X-ray tube for extended functionality and an advacned console and system mobility.
“We have integrated both clinical and patient feedback to bring to life exciting new elements with the SRT-100+—from live lesion and patient cameras for monitoring d...
Source: Mass Device - August 2, 2018 Category: Medical Devices Authors: Fink Densford Tags: Oncology Regulatory/Compliance Sensus Healthcare LLC Source Type: news
Establishment Labs prices $67m IPO
Breast implant maker Establishment Labs yesterday priced its initial public offering at $18 per share, saying it expects to gross nearly $67 million not including a possible underwriters option.
Alajuela, Costa Rica-based Establishment Labs originally registered the offering at $58 million, saying it plans to use the proceeds to fund a pre-market approval study of its Motiva implants. The FDA granted an investigational device exemption in March for the PMA study and enrolled the first patient the next month, the company said.
Yesterday the company said it’s offering some 3.7 million shares at $18 apiece, for gro...
Source: Mass Device - July 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cosmetic/Aesthetic Funding Roundup Initial Public Offering (IPO) Wall Street Beat Women's Health Establishment Labs Source Type: news
She Recorded That Heartbreaking Turtle Video. Here ’s What She Wants Companies Like Starbucks to Know About Plastic Straws
When marine biologist Christine Figgener filmed her team removing a plastic straw stuck in a sea turtle’s nose in August 2015, she says she had no idea how much it would resonate with the world. She also had no idea nearly three years later, the video would help galvanize a larger movement, which now includes companies like Starbucks and American Airlines, to eliminate plastic straws from our day-to-day lives.
The 34-year-old marine conservation biologist, who is currently finishing her Ph.D at Texas A&M University, says she was “celebrating” last week after several companies followed Starbucks’...
Source: TIME: Science - July 17, 2018 Category: Science Authors: Sophia Rosenbaum Tags: Uncategorized onetime Pollution Source Type: news
Breast implant maker Establishment Labs registers for $58m IPO
Breast implant maker Establishment Labs yesterday registered for an initial public offering worth nearly $58 million, saying it plans to use the proceeds to fund a pre-market approval study of its Motiva implants.
The FDA granted an investigational device exemption in March for the PMA study and enrolled the first patient the next month, the company said.
Alajuela, Costa Rica-based Establishment Labs said the $57.5 million flotation will also be used to pay off $5 million worth of promissory notes due to former Class Z preferred shareholders and for general corporate purposes. The company plans to trade shares on the NASD...
Source: Mass Device - June 22, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cosmetic/Aesthetic Funding Roundup Wall Street Beat Establishment Labs Source Type: news
Scientists Take A Ride On The Pacific's 'Shark Highway'
Biologists knew the sharks sometimes traveled from waters off Costa Rica south to the Galapagos Islands, but they'd never actually witnessed it.(Image credit: Andy Mann/Waitt Foundation/Pacifico ) (Source: NPR Health and Science)
Source: NPR Health and Science - May 22, 2018 Category: Consumer Health News Authors: Christopher Joyce Source Type: news
SIUE Creates Partnership with University of Costa Rica
SIUE has reached an academic partnership agreement with the University of Costa Rica (UCR). The new five-year partnership with UCR, coupled with the current faculty-led travel study programs through...(PRWeb May 14, 2018)Read the full story at https://www.prweb.com/releases/2018/05/prweb15484509.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 14, 2018 Category: Pharmaceuticals Source Type: news
SIUE Creates Partnership with University of Costa Rica
SIUE has reached an academic partnership agreement with the University of Costa Rica (UCR). The new five-year partnership with UCR, coupled with the current faculty-led travel study programs through...(PRWeb May 14, 2018)Read the full story at http://www.prweb.com/releases/2018/05/prweb15484509.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 14, 2018 Category: Pharmaceuticals Source Type: news
Biomerics, ATL Tech join up to buy Catheter Research
Biomerics and ATL Technology today announced they launched a joint venture to acquire Catheter Research Inc, including it’s assets in Indianapolis and Costa Rica.
Catheter Research Inc manufactures interventional catheters, tube sets and other assemblies for medical devices, the companies said. The company has specific expertise in tube extrusion, catheter assembly and final FDA product packaging for sterilization, and also sells its own catheter line under the brand Thomas Medical.
Read the whole story on our sister site, Medical Design & Outsourcing
The post Biomerics, ATL Tech join up to buy Catheter Research ...
Source: Mass Device - May 1, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Catheters Mergers & Acquisitions atltechnology Biomerics catheterresearchinc Source Type: news
Walking distances from home to bus stops in San Jos é, Costa Rica: real, perceived, and stated-preference distances - Rodriguez-Gonzalez MB, Aguero-Valverde J.
The distance pedestrians are willing to walk from their homes to the bus stop is of great importance for planning, modeling, design and evaluation of public transport systems. The distributional assumptions used for modeling walking distances are relevant ... (Source: SafetyLit)
Source: SafetyLit - May 1, 2018 Category: International Medicine & Public Health Tags: Pedestrians and Bicycles Source Type: news
Sensus Healthcare inks multiple distro deals, launches global expansion project
Superficial radiation therapy device developer Sensus Healthcare (NSDQ:SRTSU) today released plans for a global expansion, including new distribution agreements in China, Germany, Mexico, Cuba and Costa Rica.
Sensus makes low-energy photon X-ray systems for treating non-melanoma skin cancers, including basal cell and squamous cell carcinomas, and keloids.
The Boca Raton, Fla.-based company refers to the technology as superficial radiation therapy, and claims that the tech has been sued to “effectively and safely treat oncological and non-oncological skin conditions.”
“Following our new partnership with Cellmark...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Oncology Sensus Healthcare LLC Source Type: news
